Pacemakers Market Development And Business Intelligence
Summary
- Major factors influencing the growth of the market.
- Leading players & Top Segments.
- Geographic Overview.
Market growth influenced due to following factors-
- Increasing prevalence of CVD.
- Rising preference for these pacemakers due to their benefits over their external counterparts.
- growing number of patients with implanted pacemakers.
Global market size-
According to research report the cardiac pacemakers market is projected to reach $4.9 billion by 2023, at a CAGR of 2.0% during the forecast period.
Leading Players-
Major vendors in the cardiac pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).
Top Market Segments-
The MRI compatible pacemakers segment, by livestock, is projected to occupy the majority of the pacemaker market share and grow at the fastest rate during the forecast period.
The implantable pacemakers segment, by implantability, projected to occupy the majority of the market share and grow at the fastest rate during the forecast period.
For Details, Download PDF Brochure
Geographic Overview -
North America is estimated to account for the largest share of the market in 2018. Factors such as the rising prevalence of CVDs, growing geriatric population, increasing healthcare expenditure, and the availability of technologically advanced devices are driving the growth of the cardiac pacemakers market in North America.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.